70 related articles for article (PubMed ID: 25397586)
21. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis.
Bagnardi V; Rota M; Botteri E; Tramacere I; Islami F; Fedirko V; Scotti L; Jenab M; Turati F; Pasquali E; Pelucchi C; Galeone C; Bellocco R; Negri E; Corrao G; Boffetta P; La Vecchia C
Br J Cancer; 2015 Feb; 112(3):580-93. PubMed ID: 25422909
[TBL] [Abstract][Full Text] [Related]
22. Treatment of Multiple Primary Malignancies With PD-1 Inhibitor Camrelizumab: A Case Report and Brief Literature Review.
Wan Y; Wang Z; Yang N; Liu F
Front Oncol; 2022; 12():911961. PubMed ID: 35865468
[TBL] [Abstract][Full Text] [Related]
23. Surgical therapy for pulmonary metastasis of breast cancer.
Soh J; Komoike Y; Mitsudomi T
Transl Cancer Res; 2020 Aug; 9(8):5044-5052. PubMed ID: 35117870
[TBL] [Abstract][Full Text] [Related]
24. Incidence and relative risk of metachronous second primary cancers for 16 cancer sites, Osaka, Japan, 2000-2015: Population-based analysis.
Odani S; Tabuchi T; Nakata K; Morishima T; Kuwabara Y; Koyama S; Kudo H; Kato M; Miyashiro I
Cancer Med; 2022 Jan; 11(2):507-519. PubMed ID: 34845852
[TBL] [Abstract][Full Text] [Related]
25. A Case Series of Multiple Primary Malignancies Among Patients With Advanced Melanoma.
Ebia MI; Capone S; Ricker C; Thomas JS; Tulpule V; Kang I; D'Souza A; Freyer DR; Miller K; In GK
Cureus; 2021 Jun; 13(6):e15480. PubMed ID: 34262818
[TBL] [Abstract][Full Text] [Related]
26. The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study.
Feller A; Matthes KL; Bordoni A; Bouchardy C; Bulliard JL; Herrmann C; Konzelmann I; Maspoli M; Mousavi M; Rohrmann S; Staehelin K; Arndt V;
BMC Cancer; 2020 Jan; 20(1):51. PubMed ID: 31964352
[TBL] [Abstract][Full Text] [Related]
27. Clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapy.
Zhang Y; Ge Y; Wu X; Liu S
Onco Targets Ther; 2019; 12():2421-2430. PubMed ID: 31118660
[TBL] [Abstract][Full Text] [Related]
28. Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer.
Pruitt SL; Laccetti AL; Xuan L; Halm EA; Gerber DE
Br J Cancer; 2017 Mar; 116(6):717-725. PubMed ID: 28196065
[TBL] [Abstract][Full Text] [Related]
29. Prior cancer does not adversely affect survival in locally advanced lung cancer: A national SEER-medicare analysis.
Laccetti AL; Pruitt SL; Xuan L; Halm EA; Gerber DE
Lung Cancer; 2016 Aug; 98():106-113. PubMed ID: 27393515
[TBL] [Abstract][Full Text] [Related]
30. Estrogen withdrawal, increased breast cancer risk and the KRAS-variant.
McVeigh TP; Jung SY; Kerin MJ; Salzman DW; Nallur S; Nemec AA; Dookwah M; Sadofsky J; Paranjape T; Kelly O; Chan E; Miller N; Sweeney KJ; Zelterman D; Sweasy J; Pilarski R; Telesca D; Slack FJ; Weidhaas JB
Cell Cycle; 2015; 14(13):2091-9. PubMed ID: 25961464
[TBL] [Abstract][Full Text] [Related]
31. Synchronous and metachronous head and neck carcinomas.
Schwartz LH; Ozsahin M; Zhang GN; Touboul E; De Vataire F; Andolenko P; Lacau-Saint-Guily J; Laugier A; Schlienger M
Cancer; 1994 Oct; 74(7):1933-8. PubMed ID: 8082099
[TBL] [Abstract][Full Text] [Related]
32. Distinct patterns of occurrence, common associations, and survival of patients with second primary maligancies: A 5-year single institute experience with review of literature.
Vadgaonkar RA; Nayak SS; Doni S; Digumarti L; Mullapally SK; Digumarti R
Indian J Pathol Microbiol; 2021; 64(4):725-731. PubMed ID: 34673592
[TBL] [Abstract][Full Text] [Related]
33. Second primary cancers in the Vaud and Neuchâtel Cancer Registries.
Levi F; Randimbison L; Rafael BM; Manuela MC; La Vecchia C
Eur J Cancer Prev; 2015 Mar; 24(2):150-4. PubMed ID: 25397586
[TBL] [Abstract][Full Text] [Related]
34. Risk of prostate, breast and colorectal cancer after skin cancer diagnosis.
Levi F; Randimbison L; Te VC; Conconi MM; La Vecchia C
Int J Cancer; 2008 Dec; 123(12):2899-901. PubMed ID: 18770862
[TBL] [Abstract][Full Text] [Related]
35. Incidence of invasive cancers following squamous cell skin cancer.
Levi F; Randimbison L; La Vecchia C; Erler G; Te VC
Am J Epidemiol; 1997 Nov; 146(9):734-9. PubMed ID: 9366621
[TBL] [Abstract][Full Text] [Related]
36. Other primary systemic cancers in patients with melanoma: Analysis of balanced acral and nonacral melanomas.
Bae SH; Seon HJ; Choi YD; Shim HJ; Lee JB; Yun SJ
J Am Acad Dermatol; 2016 Feb; 74(2):333-40. PubMed ID: 26584878
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
